Lincoln Pharmaceuticals Limited (LINCOLN PHARMA LTD) aksje
LINCOLN.NS
StengtLINCOLN PHARMA LTD
Market Cap
$12,409,417,728
Om Lincoln Pharmaceuticals Limited (LINCOLN PHARMA LTD) aksje
Lincoln Pharmaceuticals Limited engages in manufacturing and trading of pharmaceutical products in India. The company offers products in the areas of anticold, antibiotic, otolaryngology, pain management, gastro, anti-malarial, anti-fungal, corticosteroids and cosmo-derma, anti-diabetic, anti-hypertensive, gynecology, cardio and CNS, respiratory system, and dyslipidemic; and branded generics. It also exports its products to approximately 60 countries, including Europe, Canada, Latin and North America, Africa, the Asia Pacific, and South East Asia. Lincoln Pharmaceuticals Limited was incorporated in 1979 and is based in Ahmedabad, India.
Selskapsinformasjon
380060 Ahmedabad, India
Analytikernes aksjeanbefalinger
Denne oversikten gir et raskt innblikk i hvordan analytikere vurderer aksjens potensial basert på deres siste analyser og kursmål.